Strategic Pharmacovigilance Checklist for Biosimilar Safety in 2025
The biosimilar market is growing rapidly due to rising healthcare demands, patent expirations of reference biologics, and a focus on cost-effective therapies. Pharmacovigilance for biosimilar products is critical to ensure patient safety, monitor potential risks, and support healthcare outcomes. This blog presents a strategic pharmacovigilance checklist for biosimilar 2025 to help PV teams proactively manage […]
Strategic Pharmacovigilance Checklist for Biosimilar Safety in 2025 Read More »